
Hosted by FWA · EN
The "LivingDiabetes Podcast" is a dedicated audio platform for anyone looking to deepen their understanding of health-related issues, focusing mainly on diabetes and endocrinology. The podcast is focused on empowering listeners with knowledge and practical advice for managing life with diabetes. Join us as we explore health-related issues, including diabetes, with the goal of enhancing the health outcomes and quality of life for those who suffer from this chronic condition.

In this episode, we cover everything you need to know about starting an exercise routine with diabetes. We explain why exercise is the closest thing to a wonder drug, break down the ADA guidelines into achievable steps, discuss how exercise timing affects blood sugar including why post-meal walks are the single best habit to add, cover safety considerations for insulin users, and explain why resistance training is especially valuable for glucose control. Follow us on social media for updates and more content.

In this episode, we explore the dangerous intersection of diabetes and eating disorders, including the life-threatening condition diabulimia where insulin is deliberately restricted for weight loss. We discuss why people with diabetes are more vulnerable to disordered eating, warning signs that are often missed, binge eating disorder in type 2 diabetes, and why integrated care from specialists who understand both conditions produces the best outcomes. Follow us on social media for updates and more content.

In this episode, we examine whether GLP-1 medications like semaglutide and tirzepatide can affect mood and mental health. We explore the science behind GLP-1 receptors in the brain, review clinical trial and real-world evidence, discuss three mechanisms through which these medications could influence mood including direct CNS effects, psychological adjustment to appetite changes, and blood sugar fluctuations, and provide practical guidance for patients and prescribers. Follow us on social media for updates and more content.

In this special World Health Day episode, we look at the global scale of the diabetes epidemic with over 540 million adults affected worldwide. We examine geographic disparities, the insulin access crisis in low-income countries, the staggering economic burden exceeding 960 billion dollars, evidence-based prevention strategies, and the bright spots including national programmes and technology bridging gaps in care. Follow us on social media for updates and more content.

In this episode, we break down the critical difference between diabetes distress and clinical depression, two conditions that look similar but require completely different treatment approaches. We explain what diabetes distress actually is, how it differs from clinical depression, why the distinction matters for treatment decisions, and how validated screening tools like the Diabetes Distress Scale and PHQ-9 can help get the right diagnosis. Follow us on social media for updates and more content.

In this episode, we explore the science behind how stress hormones, particularly cortisol, directly raise blood sugar through multiple mechanisms including liver glucose release, increased insulin resistance, and chronic inflammation. We explain the hypothalamic-pituitary-adrenal axis, review clinical evidence linking stress to higher A1C values, and provide five practical strategies for managing stress as a core component of diabetes care. Follow us on social media for updates and more content.

In this episode, we explore amycretin, Novo Nordisk's oral dual agonist that targets both GLP-1 and amylin receptors in a single molecule. We break down how it differs from injectable options like CagriSema, review the impressive early trial data showing thirteen percent weight loss in just twelve weeks, discuss why an effective oral option matters for patient access, and look at where it fits in the evolving pipeline of diabetes and obesity medications. Follow us on social media for updates and more content.

In this episode, we look at CagriSema, a next-generation combination medication that pairs semaglutide with cagrilintide, an amylin analogue. We explain how this dual-pathway approach works, review the impressive phase three clinical trial results showing A1C reductions exceeding two percentage points and weight loss of fifteen to twenty percent, discuss the side effect profile, and explore when this medication might become available. Follow us on social media for updates and more content.

Welcome back to Living Diabetes. In this episode, we dive into the fundamental question of what diabetes is and what's happening inside your body. We explain how your body processes food, the role of glucose and insulin, and what goes wrong in diabetes. We also cover the symptoms and effects of high blood glucose levels, including frequent urination, excessive thirst, weight loss, and the dangers of diabetic ketoacidosis. Finally, we touch on the importance of managing blood glucose levels, setting blood glucose targets, and understanding the differences between type one and type two diabetes. Follow us on social media for updates and more content.00:00 Introduction to Diabetes00:19 How Your Body Processes Food01:40 The Role of Insulin02:47 What Happens When the System Fails04:30 Symptoms and Body's Response05:50 Managing Diabetes06:22 Understanding the Causes06:43 Addressing Common Misconceptions07:18 Blood Glucose Targets07:50 Conclusion and Next Steps

In this episode, we discuss the newly released Dietary Guidelines for Americans, which emphasise eating real food. The updated guidelines mark a significant shift from the old food pyramid from the 1990s, focusing on high-quality protein, vegetables, fruits, and healthy fats while reducing refined carbs and processed foods. Practical tips are provided to help you implement these changes in your daily diet. Follow us on social media for updates and more content.